Fresenius Medical Care delivers solid Q3 despite impact from natural disasters in North America
. - Revenue growth of 3% (+8% at constant currency) - Operating income stable (+4% at constant currency) - North America…
. - Revenue growth of 3% (+8% at constant currency) - Operating income stable (+4% at constant currency) - North America…
. Q3/2017: - Sales €8.3 billion (+12%, +15% in constant currency) - EBIT1 €1,129 million (+5%, +9% in constant currency…
Fresenius Kabi has successfully closed the acquisition of Merck KGaA’s biosimilars business. The transaction comprises t…
Fresenius Medical Care, the world’s largest provider of dialysis products and services, has successfully refinanced its…
Fresenius Medical Care, the world’s largest provider of dialysis products and services, sees excellent future prospects…
Fresenius Medical Care, the world’s largest provider of dialysis products and services, is expanding its peritoneal dial…
Fresenius expects new record sales and earnings in the current business year. At the Annual General Meeting in Frankfurt…
. - Strong revenue increase by 14%1 supported by growth in all regions and Care Coordination activities - Net income1,2…
- Transactions provide access to attractive pharmaceutical growth markets - Acquisition of Akorn, Inc. expected to be ac…
Fresenius Medical Care, the world’s largest provider of dialysis products and services, acquires a majority stake in Cur…